DRL
Company Details
Linkedin ID:
dr--reddys-laboratories
Website:
Employees number:
30,765
Number of followers:
1,669,184
NAICS:
3254
Industry Type:
Homepage:
drreddys.com
IP Addresses:
0
Company ID:
DR._2492461
Scan Status:
In-progress
Dr. Reddy's Laboratories Company CyberSecurity Posture
drreddys.com
Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ
Dr. Reddy's Laboratories A.I CyberSecurity Scoring
DRL Risk Score (AI oriented)Between 750 and 799
DRL
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
DRL Global Score (TPRM)XXXX
DRL
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
DRL Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
DRL Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for DRL
Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)
No incidents recorded for Dr. Reddy's Laboratories in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Dr. Reddy's Laboratories in 2025.
Incident Types DRL vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Dr. Reddy's Laboratories in 2025.
Incident History — DRL (X = Date, Y = Severity)
DRL cyber incidents detection timeline including parent company and subsidiaries
DRL Company Subsidiaries
Established in 1984, we are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’, we work to provide access to affordable and innovative medicines. We offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major markets include USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in future growth drivers such as access to novel molecules, digital therapeutics and consumer healthcare. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Caution Notice: Dr. Reddy's has been made aware of candidates receiving fraudulent job opportunities from unauthorised recruiting agencies or people impersonating Dr. Reddy's leaders. These fraudulent jobs may be advertised on employment sites or mimic our careers site and company email addresses. Please know that Dr. Reddy's Laboratories has no affiliation or connection to these situations. Dr. Reddy's (and its associated/group companies) follows a formal recruitment process through its own HR department. Please report immediately in case you suspect a fraudulent job. You may raise your concern by: Accessing https://drreddys.ethicspoint.com. Calling on the hotline number. List of hotline numbers are available in https://drreddys.ethicspoint.com. The hotline is available 24x7 in multiple languages. Writing to [email protected] or [email protected]. For our community guidelines on LinkedIn, please visit: https://shorturl.at/LTvNZ
Loading...
DRL Similar Companies
Zydus Group
The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worl
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working t
MSD
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important
Hetero Drugs Ltd
Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitm
Torrent Pharmaceuticals Ltd
Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (C
Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage
UCB
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine
Parexel
Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more th
Hyderabad Pharmaceutical Congress Committee
HPCC- Hyderabad pharmaceutical congress committee is an apex body representing Indian pharmacists working in various capacities, viz,pharmaceutical industry,research and development,quality control,quality assurance,academics,drug control departments,hospitals,community and clinical pharmacy,marketi
.png)
DRL CyberSecurity News
December 11, 2025 03:59 AM
Dr. Reddy's Laboratories Records ₹32.40 Crore NSE Block Trade at ₹1,251.50 Per Share
Dr. Reddy's Laboratories recorded a significant NSE block trade worth ₹32.40 crores involving 258904 shares at ₹1251.50 per share.
November 12, 2025 08:00 AM
Dr. Reddy’s Laboratories Falls Victim to ₹2.16 Crore Cyber Fraud Through Fake Emails
Hackers impersonated vendor in email scam, diverting ₹2.16 crore payment from dr Reddy's lab.
November 11, 2025 08:00 AM
Dr. Reddy's Laboratories Thwarts Cyber Fraud Attempt, Confirms No Financial Loss
Dr Reddy's Laboratories successfully prevented a cyber fraud attempt involving vendor email impersonation. The hackers tried to redirect a...
November 10, 2025 08:00 AM
Bengaluru cyber fraud: Hackers target Dr Reddy’s Lab in scam attempt — How pharma company risked losing o
Cybersecurity News: Dr Reddy's Laboratories lost Rs 2.16 crore to fraudsters who infiltrated an email thread and rerouted a payment to a...
November 10, 2025 08:00 AM
India cyber fraud: Dr Reddy’s loses ₹2.16 crore in email impersonation scam
Dr Reddy's Laboratories in India has lost ₹2.16 crore after cyber criminals allegedly hacked email exchanges with Group Pharmaceuticals and...
November 10, 2025 08:00 AM
Cyber Fraud: Dr. Reddy’s Laboratories Loses ₹2.16 Crore After Fraudsters Hack Email Communication
Dr. Reddy's Laboratories reportedly lost ₹2.16 crore in a major cyber fraud after scammers hacked into company email exchanges.
November 09, 2025 08:00 AM
Hackers Dupe Dr. Reddy’s Laboratories Of Rs 2.16 Cr In Corporate Cyber Fraud
Dr. Reddy's Laboratories has reportedly lost Rs 2.16 crore after hackers impersonated an executive from a supplier firm and diverted funds...
November 09, 2025 08:00 AM
Dr. Reddy's Laboratories Falls Victim to Rs 2.16 Crore Email Fraud
Dr Reddy's Laboratories lost Rs 2.16 crore in a sophisticated cyber fraud scheme. Fraudsters used email spoofing to impersonate executives...
November 09, 2025 08:00 AM
Dr. Reddy’s Labs Loses ₹2.16 Crore in Cyber Fraud Hackers Divert Corporate Funds Through Email Spoofing; Bengaluru Police Launch Probe
Bengaluru|November 9, 2025: Indian pharmaceutical major Dr. Reddy's Laboratories Ltd. has reportedly fallen victim to a sophisticated corporate cyber fraud,...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
DRL CyberSecurity History Information
Official Website of Dr. Reddy's Laboratories
The official website of Dr. Reddy's Laboratories is http://www.drreddys.com.
Dr. Reddy's Laboratories’s AI-Generated Cybersecurity Score
According to Rankiteo, Dr. Reddy's Laboratories’s AI-generated cybersecurity score is 784, reflecting their Fair security posture.
How many security badges does Dr. Reddy's Laboratories’ have ?
According to Rankiteo, Dr. Reddy's Laboratories currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does Dr. Reddy's Laboratories have SOC 2 Type 1 certification ?
According to Rankiteo, Dr. Reddy's Laboratories is not certified under SOC 2 Type 1.
Does Dr. Reddy's Laboratories have SOC 2 Type 2 certification ?
According to Rankiteo, Dr. Reddy's Laboratories does not hold a SOC 2 Type 2 certification.
Does Dr. Reddy's Laboratories comply with GDPR ?
According to Rankiteo, Dr. Reddy's Laboratories is not listed as GDPR compliant.
Does Dr. Reddy's Laboratories have PCI DSS certification ?
According to Rankiteo, Dr. Reddy's Laboratories does not currently maintain PCI DSS compliance.
Does Dr. Reddy's Laboratories comply with HIPAA ?
According to Rankiteo, Dr. Reddy's Laboratories is not compliant with HIPAA regulations.
Does Dr. Reddy's Laboratories have ISO 27001 certification ?
According to Rankiteo,Dr. Reddy's Laboratories is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Dr. Reddy's Laboratories
Dr. Reddy's Laboratories operates primarily in the Pharmaceutical Manufacturing industry.
Number of Employees at Dr. Reddy's Laboratories
Dr. Reddy's Laboratories employs approximately 30,765 people worldwide.
Subsidiaries Owned by Dr. Reddy's Laboratories
Dr. Reddy's Laboratories presently has no subsidiaries across any sectors.
Dr. Reddy's Laboratories’s LinkedIn Followers
Dr. Reddy's Laboratories’s official LinkedIn profile has approximately 1,669,184 followers.
NAICS Classification of Dr. Reddy's Laboratories
Dr. Reddy's Laboratories is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
Dr. Reddy's Laboratories’s Presence on Crunchbase
No, Dr. Reddy's Laboratories does not have a profile on Crunchbase.
Dr. Reddy's Laboratories’s Presence on LinkedIn
Yes, Dr. Reddy's Laboratories maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/dr--reddys-laboratories.
Cybersecurity Incidents Involving Dr. Reddy's Laboratories
As of December 22, 2025, Rankiteo reports that Dr. Reddy's Laboratories has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Dr. Reddy's Laboratories has an estimated 5,459 peer or competitor companies worldwide.
Dr. Reddy's Laboratories CyberSecurity History Information
How many cyber incidents has Dr. Reddy's Laboratories faced ?
Total Incidents: According to Rankiteo, Dr. Reddy's Laboratories has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Dr. Reddy's Laboratories ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
A vulnerability has been found in SeaCMS up to 13.3. The affected element is an unknown function of the file js/player/dmplayer/dmku/class/mysqli.class.php. Such manipulation of the argument page/limit leads to sql injection. The attack can be executed remotely. The exploit has been disclosed to the public and may be used.
Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in HappyDevs TempTool allows Stored XSS.This issue affects TempTool: from n/a through 1.3.1.
Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Description
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Tormorten WP Microdata allows Stored XSS.This issue affects WP Microdata: from n/a through 1.0.
Risk Information
cvss3
Base: 6.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
Description
Exposure of Sensitive System Information to an Unauthorized Control Sphere vulnerability in HappyDevs TempTool allows Retrieve Embedded Sensitive Data.This issue affects TempTool: from n/a through 1.3.1.
Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description
A vulnerability has been found in Tenda FH1201 1.2.0.14(408). Affected is the function sprintf of the file /goform/SetIpBind. Such manipulation of the argument page leads to stack-based buffer overflow. The attack may be performed from remote. The exploit has been disclosed to the public and may be used.
Risk Information
cvss2
Base: 9.0
Severity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
cvss4
Base: 7.4
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
- https://github.com/z472421519/BinaryAudit/blob/main/PoC/BOF/Tenda_FH1201/SetIpBind/SetIpBind.md
- https://github.com/z472421519/BinaryAudit/blob/main/PoC/BOF/Tenda_FH1201/SetIpBind/SetIpBind.md#reproduce
- https://vuldb.com/?ctiid.337689
- https://vuldb.com/?id.337689
- https://vuldb.com/?submit.719154
- https://www.tenda.com.cn/
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=dr--reddys-laboratories' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
